XPH icon

SPDR S&P Pharmaceuticals ETF

71 hedge funds and large institutions have $259M invested in SPDR S&P Pharmaceuticals ETF in 2016 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 16 increasing their positions, 24 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership:

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding:

less first-time investments, than exits

New positions opened: | Existing positions closed:

33% less repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 24

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
71
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$104M
2
$26M
3
$19.6M
4
$18.7M
5
$17.1M
6
$15.9M
7
$10.5M
8
$4.91M
9
$4.32M
10
$4.11M
11
$3.65M
12
$2.76M
13
$2.55M
14
$2.42M
15
$2.35M
16
$2.28M
17
$1.67M
18
$1.66M
19
$1.34M
20
$1.31M
21
$1.12M
22
$1.03M
23
$843K
24
$778K
25
$647K